|
Press Release
Maxwell Imaging, P.C. Selects Aspyra RIS/PACS to Automate Center
Nov 26, 2008 CALABASAS, CALIFORNIA, November 25, 2008... Aspyra, Inc. (AMEX - APY) announced today that the Company has contracted with Maxwell Medical Imaging, P.C.,a state-of-the-art multi-modality imaging center in Lower Manhattan, New York, to provide Aspyra's AccessRAD Radiology Information System (RIS) / Picture Archive Communication System (PACS) integrated solution. Neil Mosesson, Administrator of Maxwell Medical stated, "Maxwell Medical is a patient-centric facility. We selected Aspyra's RIS/PACS because it will allow us to keep the patient first." He continued, "With use of this system, our radiologists will have online access to current and prior patient history while viewing new images. This will expedite our report turnaround to referring clinicians and increase the efficiency of our IT systems by implementing an integrated RIS/PACS solution." "Organizations such as Maxwell Medical face demanding timelines, lower reimbursement and fierce competition, while maintaining a high standard quality care," stated Bill Culton, Aspyra Diagnostic Solutions Product Manager. He continued, "From our appointment scheduling and pre-authorization worklists to management of outside reads and images, AccessRAD will enable Maxwell Medical to improve productivity, view more images and capture the necessary codes to properly bill for exams and services performed, with a single product solution." Aspyra's AccessRAD RIS/PACS is designed to meet the needs of acute care hospitals, enterprise-wide delivery networks, and medium to large imaging centers, with end-to-end solutions that automate processes at every point of patient and imaging encounter workflow. Aspyra will be demonstrating AccessRAD RIS/PACS at the RSNA 2008 Annual Conference, held at the McCormick Convention Center in Chicago, November 30 - December 4, 2008. Aspyra will be at booth 6610, South Hall. Safe Harbor Statement This press release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to anticipated revenues, expenses, earnings, operating cash flows, the outlook for Aspyra's markets and the demand for its products. Forward-looking statements are not guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statements. Such statements are based upon, among other things, assumptions made by, and information currently available to, management, including management's own knowledge and assessment of the Company's industry and competition. Factors that could cause Aspyra's actual results to differ materially from these forward-looking statements include among others: whether the combined company will realize the potential benefits of the merger; the competitive environment; unexpected technical and marketing difficulties inherent in major product development efforts; the potential need for changes in our long-term strategy in response to future developments; future advances in clinical information technology and procedures, as well as potential changes in government regulations and healthcare policies; and rapid technological change in the microelectronics and software industries. The Company refers interested persons to its most recent Annual Report on Form 10-KSB and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The Company assumes no duty to update its forward-looking statements. More Press Releases | Top Copyright © 2006 Aspyra. All rights reserved. Privacy & Legal |
